CompletedNCT04666025

SARS-CoV-2 Donor-Recipient Immunity Transfer

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
City of Hope Medical Center
Principal Investigator
Monzr M Al Malki
City of Hope Comprehensive Cancer Center
Intervention
Biospecimen Collection(procedure)
Enrollment
26 enrolled
Eligibility
18 years · All sexes
Timeline
20202023

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04666025 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials